Compare AMPH & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | BFS |
|---|---|---|
| Founded | 1996 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 902.2M |
| IPO Year | 2005 | 1996 |
| Metric | AMPH | BFS |
|---|---|---|
| Price | $28.85 | $28.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $24.50 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 415.9K | 118.1K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 8.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.67 | 0.78 |
| Revenue | ★ $719,887,000.00 | $289,843,000.00 |
| Revenue This Year | $3.81 | $7.69 |
| Revenue Next Year | $4.91 | $3.08 |
| P/E Ratio | ★ $17.10 | $36.57 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $16.65 | $28.13 |
| 52 Week High | $31.00 | $38.42 |
| Indicator | AMPH | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 64.24 | 37.90 |
| Support Level | $27.24 | N/A |
| Resistance Level | $29.35 | $35.04 |
| Average True Range (ATR) | 1.07 | 0.65 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 61.97 | 17.07 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.